Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 975 participants.
Also called NCT01368536
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 975 participants
- Sponsor
- Registry
-
NCT01368536
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Puerto Rico
- Registry status
- Terminated
Technical summary
Registry record NCT01368536. Randomized; triple masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2013-03-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
- Acronym
- VALENCIA
- Condition
- Hypertension
- Condition
- Stage 2 Hypertension
- Condition
- Diabetes
- Intervention (Drug)
- Valturna
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Chlorthalidone
- Intervention (Drug)
- Placebo of Valturna Tablet
- Intervention (Drug)
- Placebo Capsule
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01368536- Content hash
91fad5ba8c5739393433dab957ab735d663f226791ca0dc69c478f1659b619d8